SCIENTIFIC HUB

Follow the evidence.

190.756 articles found

Open access

Opicapone in Parkinson's disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefit.

Pellicano C, Belvisi D, Bovenzi R, Costanzo M, De Bartolo MI, Sommaruga F, Blandino J, Modugno N, Piras F, Pierantozzi M, Stefani A, Fabbrini G, Schirinzi T.

J Neural Transm (Vienna) · 2025-08-31

DOI: 10.1007/s00702-025-03000-3PMID: 40886228

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Elevated hexosylceramides in Parkinson's disease cause gene upregulations in neurons mimicking responses to pathogens.

Franck L, Hahnefeld L, Valek L, Klatt-Schreiner K, Wilken-Schmitz A, Alnouri MW, Trautmann S, Weyer MP, Thomas D, Gurke R, Offermanns S, Geisslinger G, Tegeder I.

NPJ Parkinsons Dis · 2025-08-30

DOI: 10.1038/s41531-025-01114-9PMID: 40885755

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.